<DOC>
	<DOCNO>NCT01262560</DOCNO>
	<brief_summary>RATIONALE : Manuka honey may prevent reduce esophagitis-related pain cause chemotherapy radiation therapy . It yet know whether Manuka honey effective standard care prevent pain . PURPOSE : This randomized phase II clinical trial study Manuka honey see well work prevent esophagitis-related pain patient receive chemotherapy radiation therapy lung cancer .</brief_summary>
	<brief_title>Manuka Honey Preventing Esophagitis-Related Pain Patients Receiving Chemotherapy Radiation Therapy For Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Evaluate relative efficacy 4 time day consumption liquid lozenge Manuka honey delay prevent radiation esophagitis-related pain ( combine chemotherapy radiation therapy lung cancer ) compare standard supportive treatment , measure week 4 Numerical Rating Pain Scale ( NRPS ) pain upon swallow . Secondary - Evaluate trend severity radiation esophagitis-related pain combine chemotherapy radiation therapy lung cancer use weekly measurement NRPS . - Evaluate adverse event associate Manuka honey , measure CTCAE , v. 4 . - Evaluate severity radiation esophagitis ( grade 3-4 , CTCAE , v. 4 ) . - Assess weight loss ( percent weight change baseline 4 week ) . - Assess quality life ( QOL ) pain , measure European Organization Research Treatment Cancer ( EORTC ) Quality Life Questionnaire ( QLQ-30 ) global QOL score pain symptom subscale . - Assess patient-reported dysphagia via daily patient log . - Assess nutritional status , measure mean change serum prealbumin level baseline 4 week . - Assess opioid use collect patient 's narcotic use previous 24-hour period weekly evaluation . - Evaluate patient-reported adverse event associate Manuka honey use PRO-CTCAE . OUTLINE : This multicenter study . Patients stratify accord percentage esophagus radiation field ( V60 &lt; 30 % v V60 â‰¥ 30 % ) . Patients randomize 1 3 treatment arm . - Arm I : Patients receive standard supportive care esophagitis-related pain need chemoradiotherapy . - Arm II : Patients swallow liquid Manuka honey slowly 3-5 minute . Patients must refrain eat drink 1 hour administration . Treatment continue 4 time per day chemoradiotherapy . - Arm III : Patients place Manuka honey lozenges mouth one time swallow honey dissolve ( chew swallow whole ) . Patients must refrain eat drink 1 hour administration . Treatment continue 4 time per day chemoradiotherapy . Patients complete quality life , pain swallow diary , pain assessment ( Numerical Rating Pain Scale , EORTC ALA-30 Pain Subscale , PRO-CTCAE ) periodically study treatment . Patients follow 12 week start study treatment .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , drug combination</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients treat combination chemotherapy ( definitive adjuvant ) radiation therapy daily small cell nonsmall cell lung cancer ( primary population trial ) Patients receive chemoradiotherapy Radiation Therapy Oncology Group ( RTOG ) lung trial clinical trial No patient receive chemoradiotherapy enrol single institution trial trial coordinate cooperative group No patient metastatic disease At least 5 cm esophagus must 60 Gy isodose volume 1.6 2.0 Gy fraction PATIENT CHARACTERISTICS : Age 18 Able swallow thick liquid prior treatment Able speak English Spanish order complete require form ( verbal completion adequate ) No patient poorly control diabetes No known hypersensitivity honey PRIOR CONCURRENT THERAPY : See Disease Characteristics No patient receive prior chemotherapy radiation therapy No patient receive daily treatment Therapeutic use honey Manuka honey provide trial allow patient study Patients must also avoid honeyflavored medical product and/or sugary , viscous substance Amifostine permit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>dysphagia</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IA non-small cell lung cancer</keyword>
	<keyword>stage IB non-small cell lung cancer</keyword>
	<keyword>stage IIA non-small cell lung cancer</keyword>
	<keyword>stage IIB non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>esophagitis</keyword>
</DOC>